301 related articles for article (PubMed ID: 31033184)
1. Role of broad-spectrum sunscreen alone in the improvement of melasma area severity index (MASI) and Melasma Quality of Life Index in melasma.
Sarkar R; Ghunawat S; Narang I; Verma S; Garg VK; Dua R
J Cosmet Dermatol; 2019 Aug; 18(4):1066-1073. PubMed ID: 31033184
[TBL] [Abstract][Full Text] [Related]
2. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy.
Cestari TF; Hexsel D; Viegas ML; Azulay L; Hassun K; Almeida AR; Rêgo VR; Mendes AM; Filho JW; Junqueira H
Br J Dermatol; 2006 Dec; 156 Suppl 1():13-20. PubMed ID: 17176300
[TBL] [Abstract][Full Text] [Related]
3. Does using a high sun protection factor sunscreen on face, along with physical photoprotection advice, in patients with melasma, change serum vitamin D concentration in Indian conditions? A pragmatic pretest-posttest study.
Singh S; Jha B; Tiwary NK; Agrawal NK
Indian J Dermatol Venereol Leprol; 2019; 85(3):282-286. PubMed ID: 30409925
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a Hindi language health-related quality of life questionnaire for melasma in Indian patients.
Sarkar R; Garg S; Dominguez A; Balkrishnan R; Jain RK; Pandya AG
Indian J Dermatol Venereol Leprol; 2016; 82(1):16-22. PubMed ID: 26728805
[TBL] [Abstract][Full Text] [Related]
5. Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
Sahu PJ; Singh AL; Kulkarni S; Madke B; Saoji V; Jawade S
J Cosmet Dermatol; 2020 Jun; 19(6):1456-1462. PubMed ID: 32346962
[TBL] [Abstract][Full Text] [Related]
6. Clinical and epidemiologic features of melasma: a multicentric cross-sectional study from India.
Sarkar R; Jagadeesan S; Basavapura Madegowda S; Verma S; Hassan I; Bhat Y; Minni K; Jha A; Das A; Jain G; Arya L; Mandlewala Z; Bagadia J; Garg V
Int J Dermatol; 2019 Nov; 58(11):1305-1310. PubMed ID: 31187480
[TBL] [Abstract][Full Text] [Related]
7. Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial.
Castanedo-Cazares JP; Hernandez-Blanco D; Carlos-Ortega B; Fuentes-Ahumada C; Torres-Álvarez B
Photodermatol Photoimmunol Photomed; 2014 Feb; 30(1):35-42. PubMed ID: 24313385
[TBL] [Abstract][Full Text] [Related]
8. Combined use of two formulations containing diacetyl boldine, TGF-β1 biomimetic oligopeptide-68 with other hypopigmenting/exfoliating agents and sunscreen provides effective and convenient treatment for facial melasma. Either is equal to or is better than 4% hydroquinone on normal skin.
Pratchyapurit WO
J Cosmet Dermatol; 2016 Jun; 15(2):131-44. PubMed ID: 26833454
[TBL] [Abstract][Full Text] [Related]
9. Validation of a melasma quality of life questionnaire for the Turkish language: the MelasQoL-TR study.
Dogramaci AC; Havlucu DY; Inandi T; Balkrishnan R
J Dermatolog Treat; 2009; 20(2):95-9. PubMed ID: 18720186
[TBL] [Abstract][Full Text] [Related]
10. Combination of glycolic acid peel and topical 20% azelaic acid cream in melasma patients: efficacy and improvement in quality of life.
Dayal S; Sahu P; Dua R
J Cosmet Dermatol; 2017 Mar; 16(1):35-42. PubMed ID: 27500896
[TBL] [Abstract][Full Text] [Related]
11. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
Adalatkhah H; Sadeghi-Bazargani H
Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the effects of skin microneedling as adjuvant therapy for facial melasma: a pilot study.
Lima EVA; Lima MMDA; Paixão MP; Miot HA
BMC Dermatol; 2017 Nov; 17(1):14. PubMed ID: 29183309
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma.
Guevara IL; Pandya AG
Int J Dermatol; 2003 Dec; 42(12):966-72. PubMed ID: 14636195
[TBL] [Abstract][Full Text] [Related]
14. Effect of melasma on quality of life in a sample of women living in southern Brazil.
Freitag FM; Cestari TF; Leopoldo LR; Paludo P; Boza JC
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):655-62. PubMed ID: 18410339
[TBL] [Abstract][Full Text] [Related]
15. Skin-lightening effects of a new face care product in patients with melasma.
Scherdin U; Bürger A; Bielfeldt S; Filbry A; Weber T; Schölermann A; Wigger-Alberti W; Rippke F; Wilhelm KP
J Cosmet Dermatol; 2008 Mar; 7(1):68-75. PubMed ID: 18254815
[TBL] [Abstract][Full Text] [Related]
16. Is There a Correlation between Severity of Melasma and Quality of Life?
Jusuf NK; Putra IB; Mahdalena M
Open Access Maced J Med Sci; 2019 Aug; 7(16):2615-2618. PubMed ID: 31777617
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the quality of life among melasma patients using the MELASQoL scale: A systematic review and meta-analysis.
Zhu Y; Zeng X; Ying J; Cai Y; Qiu Y; Xiang W
PLoS One; 2022; 17(1):e0262833. PubMed ID: 35085327
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Trichloro-Acetic Acid Peel Alone Versus Combined Topical Magnesium Ascorbyl Phosphate for Epidermal Melasma.
Murtaza F; Bangash AR; Khushdil A; Noor SM
J Coll Physicians Surg Pak; 2016 Jul; 26(7):557-61. PubMed ID: 27504543
[TBL] [Abstract][Full Text] [Related]
19. Topical 5% tranexamic acid with 30% glycolic acid peel: An useful combination for accelerating the improvement in melasma.
Sahu P; Dayal S; Bhardwaj N
Dermatol Ther; 2021 Nov; 34(6):e15107. PubMed ID: 34423510
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled pilot study of a proprietary combination versus sunscreen in melasma maintenance.
Chatterjee M; Neema S; Rajput GR
Indian J Dermatol Venereol Leprol; 2021; 88(1):51-58. PubMed ID: 34379946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
